atezolizumab
roche
['sclc', 'lcsm,(-blcsm)', 'atezo', 'nsclc', 'atezo-brain']
dr nadal provides updates from the atezo-brain trial. atezo plus carbo and peme in patients with adv nonsquam has promising 2-year os rate and intracranial response rate, regardless of tx with corticosteroids at baseline and pd-l1 expresn. #nsclc #asco22 #lcsm 
LUNGevity Foundation is dedicated to funding lung cancer research and providing support to ALL people affected by lung cancer.